OptimizeRx (OPRX)
(Delayed Data from NSDQ)
$9.16 USD
+0.22 (2.46%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $9.14 -0.02 (-0.22%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
OptimizeRx Corp. (OPRX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$14.57 | $20.00 | $8.00 | 62.98% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for OptimizeRx Corp. comes to $14.57. The forecasts range from a low of $8.00 to a high of $20.00. The average price target represents an increase of 62.98% from the last closing price of $8.94.
Analyst Price Targets (7 )
Broker Rating
OptimizeRx Corp. currently has an average brokerage recommendation (ABR) of 1.43 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.50 a month ago based on six recommendations.
Of the seven recommendations deriving the current ABR, five are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 71.43% and 14.29% of all recommendations. A month ago, Strong Buy made up 66.67%, while Buy represented 16.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 4 | 4 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.43 | 1.43 | 1.50 | 1.50 | 1.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/9/2024 | Roth Capital Partners | Richard K Baldry | Strong Buy | Strong Buy |
4/4/2024 | JMP Securities | Constantine Kyriakos Davides | Not Available | Strong Buy |
4/1/2024 | Lake Street Capital Markets | Eric Martinuzzi | Strong Buy | Strong Buy |
3/28/2024 | William Blair | Ryan S Daniels | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.43 |
ABR (Last week) | 1.43 |
# of Recs in ABR | 7 |
Average Target Price | $14.57 |
LT Growth Rate | NA |
Industry | Computer - Software |
Industry Rank by ABR | 87 of 252 |
Current Quarter EPS Est: | -0.11 |